<DOC>
	<DOCNO>NCT01113112</DOCNO>
	<brief_summary>The purpose study understand relationship behavioral factor , hormone , chemical produce body may help tumor growth ovarian cancer .</brief_summary>
	<brief_title>Biobehavioral-Cytokine Interactions Ovarian Cancer</brief_title>
	<detailed_description>Ovarian cancer second common gynecologic cancer . Because low rate survival majority ovarian cancer patient , identification factor contribute tumor progression paramount importance . Epidemiologic study suggest association biobehavioral factor life stress , depression , low social support cancer progression . Direct link demonstrate biobehavioral factor cytokine support angiogenesis , formation new blood vessel enhance tumor growth progression . However , little known regard tumor associate macrophage ( TAM ) interaction TAM tumor cell way favor tumor growth , preliminary data indicate ovarian cancer patient high level depressive symptom life stress great TAM production matrix metalloproteinase-9 , key molecule promote angiogenesis tumor invasion . We also preliminary data ovarian cancer patient high level depressive symptom accompany low social support great tumor expression number gene relate inflammation tumor progression .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<criteria>Patients histologic diagnosis epithelial ovarian cancer , primary peritoneal carcinoma , fallopian tube cancer ; FIGO stage I IV define surgically completion initial abdominal surgery appropriate tissue available histologic evaluation . Patients follow histologic epithelial cell type eligible : serous adenocarcinoma , endometrioid adenocarcinoma , mucinous adenocarcinoma , undifferentiated carcinoma , clear cell carcinoma , mixed epithelial carcinoma , adenocarcinoma otherwise specify . However , histologic feature must compatible primary Mullerian epithelial adenocarcinoma . GOG performance status 03 Patients diagnosis borderline epithelial ovarian tumor ( formerly : tumor low malignant potential '' recurrent invasive epithelial ovarian , primary peritoneal , fallopian tube cancer treat chemotherapy radiotherapy previously exclude . Patients receive neoadjuvant chemotherapy ovarian , primary peritoneal , fallopian tube carcinoma exclude . Nonepithelial ovarian cancer metastasis ovary organ exclude . Previous cancer diagnosis except basal cell carcinoma skin history lymphoma . Pregnancy age &lt; 18 year old Use systemic glucocorticoid prednisone decadron last 30 day Comorbid condition : Addison 's disease , autoimmune hepatitis , hepatitis B , hepatitis C , AIDS HIV , lupus erythematosus , mixed connective tissue disease , rheumatoid arthritis . Inability accurately answer question ( e.g . condition dementia )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Ovarian Neoplasms</keyword>
</DOC>